Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-022)
Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-022) is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-022) have?
Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-022) has 1 citations in the OpenAlex counts ScholarIQ stores.
When was Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-022) published?
Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-022) has 2019 year in the ScholarIQ index.
What is the open-access status of Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-022)?
Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-022) has closed oa status in the ScholarIQ index.
What is the DOI of Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-022)?
The DOI for Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-022) is on the source record.
What is the OpenAlex record for Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-022)?
The OpenAlex for Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-022) is on the source record.